Sio Capital Management »

Aslan Pharmaceuticals shares owned by Sio Capital Management

Quarter-by-quarter ownership of Aslan Pharmaceuticals (ASLN) shares owned by Sio Capital Management from 13F filings

Historical chart of Sio Capital Management investment in Aslan Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aslan Pharmaceuticals held by Sio Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aslan Pharmaceuticals by Sio Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $478k 254k 1.88
2023-06-30 $928k 254k 3.65
2023-03-31 $732k 254k 2.88

More positions owned by Sio Capital Management

Laboratory Corp Amer Hldgs Com New (LH)
Globus Med Cl A (GMED)
GSK Sponsored Adr (GSK)
United Therapeutics Corporation (UTHR)
Cigna Corp (CI)
Ge Healthcare Technologies I Common Stock (GEHC)
Bicycle Therapeutics Sponsored Ads (BCYC)
Pfizer (PFE)
Organon & Co Common Stock (OGN)
Teleflex Incorporated (TFX)
Regeneron Pharmaceuticals (REGN)
Medtronic SHS (MDT)
Embecta Corp Common Stock (EMBC)
Healthcare Services (HCSG)
Orthofix Medical (OFIX)

View all positions for Sio Capital Management

Top funds holding Aslan Pharmaceuticals

BVF
UBS Group
Citadel Advisors
Shay Capital
Landscape Capital Management
Millennium Management
Waterfront Wealth
Ikarian Capital
Schonfeld Strategic Advisors
Jane Street
Onyx Bridge Wealth Group
Capital Analysts
Rhumbline Advisers
Cutler

View all funds holding Aslan Pharmaceuticals